Analyst Remains Confident In Corium Despite Bad FDA News By: Benzinga via Benzinga December 27, 2017 at 11:19 AM EST The U.S. Food and Drug Administration sent an unfavorable Complete Response Letterlast week to Agile Therapeutics Inc (NASDAQ: ... Read More >> Related Stocks: Agile Therapeutics Inc Corium Intl